Antengene Announces ATG-101 Granted Orphan Drug Designation by the U.S. FDA ...Middle East

PR Newswire - News
Antengene Announces ATG-101 Granted Orphan Drug Designation by the U.S. FDA
SHANGHAI and BUCKS COUNTY, Pa., Sept. 18, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class...

Hence then, the article about antengene announces atg 101 granted orphan drug designation by the u s fda was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Antengene Announces ATG-101 Granted Orphan Drug Designation by the U.S. FDA )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News